Eclipsia+ 27.12 MHz
Advanced Thermocoagulation System
A more advanced, more efficient and more comfortable thermocoagulation technology than those currently available in the market, this is what you get with the Eclipsia+ 27.12 MHz. This innovative system, using the 27.12 MHz ultrafast radiofrequency, provides for a quick and safe cosmetic treatment of all types of skin imperfections such as telangiectases, spider veins, cherry angiomas, milia, keratosis, skin tags, pigmentation spots and minor acne problems.
* Only the treatment of skin vascular imperfection is registered at Health Canada.
Faster Results
The Eclipsia advanced thermocoagulation system uses a 27.12 MHz ultrafast radiofrequency to quickly eliminate all types of superficial skin imperfections. Since this frequency is up to 7 times faster, the Eclipsia generates the required energy in less time than other devices in its category, thus producing quicker and better coagulation results.
Incomparable Comfort
Thanks to its 27.12 MHz ultrafast radiofrequency and exclusive application techniques, the Eclipsia offers an unparalleled level of comfort. In fact, the treatment is performed so quickly that the sensation is barely noticeable by the patient. Mere thousandths of a second are enough to eliminate the unwanted imperfection! By offering such a high level of comfort, the Eclipsia has become the preferred solution for all body areas and types of patients, including the most sensitive ones!
User Friendly Interface
The Eclipsia+ incorporates a user friendly interface that is easily adaptable to a variety of cosmetic skin care. It includes 110 programs covering a mix of skin imperfections, either on the face or the body. In just a few seconds, the program guides the operator through the configuration of treatment settings according to the anomaly to be treated, whichever mode is selected.
Stability Control
Unique to Eclipsia+ technology, the current control circuit offers an exceptional level of stability. It systematically monitors the intensity of the current according to the impedance of the treated area. Furthermore, the Watch-Dog system continuously monitors the control circuit activity in order to immediately discontinue all current outputs in the event of an anomaly.
Safe and Convenient Treatment
The powerful Eclipsia+ 27.12 MHz radiofrequency is controlled by a microprocessor capable of delivering very short pulses in thousandths of a second, compared to other devices where heat diffusion is up to one hundred times longer, causing more irritation and pain. The Eclipsia+ 27 MHz radiofrequency is so fast that it minimizes collateral damage in the tissues and skin reactions on the surface, all this without the necessity of using topic analgesics. In this manner, the patient does not experience any secondary effects or periods of recuperation.
Why Use the ISM 27.12 MHz Frequency?
The main advantage of this frequency is the ultrafast change of polarity, from positive to negative, represented by its 27.12 million cycles (Hertz) per second. The ultrafast polarity change distinguishes the Eclipsia from others since it coagulates tissues much faster than conventional devices. This speed allows extremely fast application times, making the cosmetic treatment of skin imperfections much more comfortable.
Moreover, extensive research shows that at 27.12 MHz, the destruction zone is concentrated closer to the probe, where the imperfection is located. Since the neighbouring tissues are not affected by heat, the comfort is unparalleled. At 3 or 4 MHz, a larger model of heat is produced. This heat penetrates much deeper into the skin, thus inducing discomfort and unwanted collateral skin reactions.
Another technical explanation is the fact that the 27.12 MHz frequency allows for a better absorption of the power by the water molecules contained in the skin. It then takes less power at a frequency of 27.12 MHz to perform a thermocoagulation treatment than it would at a slower frequency. With the same amount of power, the 27.12 MHz signal is then applied for a shorter period of time, which increases the level of comfort for the patient and reduces the risk of undesirable skin reactions.
Benefits for Patients
Very comfortable cosmetic skin treatment due to the 27.12 MHz ultrarapid frequency.
- Immediate visible results.
- Safe on any skin type and color.
- No undesired skin reaction when performed properly.
- No local anaesthesia needed.
- No compression stockings or bandages needed.
- No side effects or allergies.
- No recuperation time, because skin regeneration is very rapid in the days following the treatment.
Benefits for Physicians
- Up to 7 times faster than the frequency used by competitor systems.
- Effective treatments, accessible to a wide variety of patients.
- Can be used in all face and body areas including sensitive zones such as the nose, eyelids, etc.
- Can be combined to sclerotherapy.
- Low operation cost.
Features
- 110 programs for face and body.
Powerful circuit with 27.12 MHz ISM monopolar frequency.
- Fully microprocessor controlled.
- Control of treatment time in thousandths of a second.
- Unique TeleFlash and MicroCoagul modes.
- Easy-care tactile keyboard.
- User friendly interface.
- Quick return on investment.
- Meets medical certification 60601-1-2 and EMC
Clinical Study
27 MHz Radiofrequency on Benign Cutaneous Lesions
Made in 2013 under the direction of Dong Hyun Kim, M.D1, 2, Lucie Germain, Ph.D.1 and Danielle Larouche, Ph.D.1, 2
1 Centre LOEX de l’Université Laval,
2 Centre de recherche du Centre Hospitalier Universitaire (CHU) de Québec, Axe médecine régénératrice, and Département de Chirurgie, Faculté de Médecine, Université Laval, Québec, QC, Canada.
Telangiectasia before treatment
June 13th, 2013
Telangiectasia after 1 treatment
July 4th, 2013
Campbell spot before treatment
September 10th, 2013
Campbell spot after 1 treatment
October 1st, 2013
Cherry angioma before treatment
June 13th, 2013
Cherry angioma after 1 treatment
July 4th, 2013
Skin tag before treatment
June 13th, 2013
Skin tag after 1 treatment
July 4th, 2013
Keratosis before treatment
September 10th, 2013
Keratosis after 1 treatment
October 1st, 2013